Drug profile · INN
levothyroxine sodium
LEVOTHYROXINE SODIUM
levothyroxine sodium (LEVOTHYROXINE SODIUM) is a thyroid hormone receptor agonist. Associated with MAIA Biotechnology. Route of administration: oral. Current US regulatory status: approved.
Drug details — levothyroxine sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 6
- Data quality
- 0.89
Quick answer
levothyroxine sodium (LEVOTHYROXINE SODIUM) is a thyroid hormone receptor agonist. Associated with MAIA Biotechnology. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Thyroid hormone receptor agonist
Primary target: Thyroid hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is levothyroxine sodium?
levothyroxine sodium (LEVOTHYROXINE SODIUM) is a thyroid hormone receptor agonist. Associated with MAIA Biotechnology. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for levothyroxine sodium?
LEVOTHYROXINE SODIUM is a marketed brand name for levothyroxine sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levothyroxine sodium?
levothyroxine sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.